The Process Development Blog

Harnessing the power of CFD to optimize process equipment cleaning protocols

When commercial impurity standards don't exist, custom synthesis unblocks QC. APC used protection-deprotection chemistry to achieve >99% purity at gram scale.

Five orthogonal protein aggregation analysis techniques explained—SEC, tryptophan fluorescence, aggregation index, NTA, and dye-binding assays—for biologic development teams.

Learn how a good numerical modeling strategy can help scale-up of single-use bioreactors.

[WEBINAR] Scale-up of crystallization processes is rarely trivial & often necessitates careful consideration and in-depth understanding of process parameters.

APC's Medicine Accelerator combines a €25M investment, iAchieve® digital platform, and 200+ scientists to accelerate CMC development and regulatory submissions.

APC unveils €25m investment and 120 jobs to accelerate development and manufacture of Covid Vaccines and Advanced Therapeutics.

Computational solvent screening narrows 70 candidates to under 10 in 2–3 days, with solubility predictions within 20% of experiment—applied to API crystal morphology design.

Combining laser light scattering and microscopy for pharmaceutical particle size analysis eliminates common measurement artefacts and provides verifiable, morphology-aware results.

[WEBINAR] Industry bottlenecks in drug substance development: solubility, particle size, and morphology.